MACH, Mateusz,DZIDA, Radoslaw,SMUGA, Damian,STELMACH, Filip,MATLOKA, Mikolaj,BAZYDLO, Katarzyna,DUBIEL, Krzysztof,WIECZOREK, Maciej,PIECZYKOLAN, Jerzy
申请号：
AU2019205093
公开号：
AU2019205093A1
申请日:
2019.01.07
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
A compound of the formula (I)wherein R represents a straight or branched, primary or secondary acyclic hydrocarbyl C3–C15 group, which can be saturated or unsaturated, or a straight or branched, primary or secondary acyclic hydrocarbyl C3–C15 group, which can be saturated or unsaturated and wherein one or more of hydrogen atoms is replaced with fluorine atom； X represents hydrogen atom or halogen atom,and* denotes chiral center, and salts thereof. The compound is useful for the treatment of diseases mediated by GPR40, in particular type II diabetes. (I)
